Clinical Trials

Clinical Trials

SAGE Oncology has a robust Oncology service which includes 10 Medical Oncologists and 1 Radiation Oncologist. The Oncology teams are committed to contributing to the advancement of medicine, and to helping their patients with clinical trials. Here are the trials in which we are participating.

Canine Cancer Tissue Study

Predicting the Right Treatment for the Right Patient

Chris Apfel, MD, PhD, MBA and Juliana Baratta, MS

Every tumor is different and therefore it has been difficult to predict which therapy is likely to be most effective. The development of next generation sequencing has enabled oncologists to get a better understanding of the underlying genomic mutation and mechanism of an individual cancer. Unfortunately, in the vast majority of cases, a relevant mutation cannot be identified and as of today it is not possible to accurately predict the most effective therapy.

However, the goal of the collaboration between SageMedic Corp. and SAGE Veterinary Centers is to change that. SageMedic Corp. has developed the SAGE Direct Test™ and here is how it works. A patient’s live tumor biopsy will be taken to create in-vitro hundreds of 3D-microtumors that are similar to the patient’s original tumor. Those live, in-vitro microtumors will then be exposed to various treatment options and within less than a week, SageMedic will be able to identify the most effective therapy. We are excited to expand our SAGE Direct Test™ to the veterinarian practice in order to improve the lives of beloved pets and their owners once our development is complete.

Because this is still in the research stage, there is not cost to participate in the study. If you want to learn more about the study, please talk to your oncologist and visit our SageMedic Corp. website.

This trial is available at SAGE Campbell, Dublin, and Redwood City Hospitals.

Feline Lymphoma Study
Feline Lymphoma study: We are partnered with ImpriMed a biomedical company in Palo Alto, to evaluate canine lymphoma cells and their response to specific chemotherapy drugs. If a client volunteers their cat lymphoma cells, we sample a patient’s lymph node with a fine-needle aspirate and ImpriMed keeps these cells alive in cell culture, exposes them to a series of chemotherapy drugs, and determines cell viability at various concentrations of drugs. While there is no financial incentive for the client/patient, the benefit is the contribution to advancing oncology treatments. This study is currently in pilot study phase and is being used to help form a future study for feline lymphoma patients to promote a personalized medicine approach to care.
SAGE Dublin, Redwood City, and Campbell are participating.
Osteosarcoma & Lung Tumor Trial

PetCure Onocology Osteosarcoma Trial:

PetCure Oncology Lung Tumor Trial:

Canine Lymphoma

SAGE is enrolling canine lymphoma patients in a study to evaluate the benefits of an Industrial Hemp product while patients are undergoing standard chemotherapy. Patients are randomized to either receive the industrial hemp product or placebo during the study. Clients and doctors are blinded to the randomization. The study will provide some financial assistance for chemotherapy and labwork during the study.

SAGE Dublin, Redwood City, Concord and Campbell are participating.

Please check this page regularly for clinical trial posts. You may also follow us on Facebook, LinkedIn, Twitter and Instagram to receive updates.


Tora Hohn

Bio Coming Soon

Contact Tora

2 + 1 =

Contact this Location

Captcha Code

COVID-19 Information